CHRONIC CHRONIC VISUAL LOSS VISUAL LOSS Wasu Supakornthanasarn, - - PowerPoint PPT Presentation

chronic chronic visual loss visual loss
SMART_READER_LITE
LIVE PREVIEW

CHRONIC CHRONIC VISUAL LOSS VISUAL LOSS Wasu Supakornthanasarn, - - PowerPoint PPT Presentation

CHRONIC CHRONIC VISUAL LOSS VISUAL LOSS Wasu Supakornthanasarn, MD. Visual loss Sensory pathway y p y Refractive errors Refractive errors Cloudy of ocular media Cloudy of ocular media Functional visual loss Functional visual loss


slide-1
SLIDE 1

CHRONIC CHRONIC VISUAL LOSS VISUAL LOSS

Wasu Supakornthanasarn, MD.

slide-2
SLIDE 2

Visual loss

Refractive errors Cloudy of ocular media Sensory pathway Functional visual loss Refractive errors Cloudy of ocular media y p y abnormalities Functional visual loss 1.1 myopia 2 1 acute/subacute 3 1 acute/subacute Amblyopia Malingering 1 2 hyperopia 2.1 acute/subacute 2 2 gradual/chronic 3.1 acute/subacute 3 2 gradual/chronic Malingering Hysteria 1.2 hyperopia 2.2 gradual/chronic 3.2 gradual/chronic 1.3 astigmatism 3.3 transient

slide-3
SLIDE 3

Refractive errors Refractive errors

  • Myopia
  • Hyperopia
  • Hyperopia
  • Astigmatism
slide-4
SLIDE 4

Cloudy of ocular media Cloudy of ocular media

  • Acute/subacute
  • AACG
  • Gradual/chronic
  • Cataract
  • Corneal ulcer
  • Acute anterior and

Cataract

  • Chronic anterior and

posterior uveitis posterior uveitis

  • Ocular trauma

p

  • Corneal decompensation
  • Dry eye
  • Vitreous hemorrhage
  • Infection

y y

slide-5
SLIDE 5

Sensory pathway abnormalities Sensory pathway abnormalities

  • 1. Acute/subacute
  • Retinal detachment
  • 2. Gradual/chronic
  • Diabetic retinopathy
  • Retinal vv. occlusion
  • Retinitis (various causes)
  • POAG
  • ARMD
  • Optic neuritis
  • ARMD
  • Intoxication ; CQ
  • 3. Transient
  • Papilledema
  • Migraine

A i f

  • Amaurosis fugax
  • Retina edema
slide-6
SLIDE 6

Visual loss

Refractive errors Cloudy of ocular media Sensory pathway Functional visual loss Refractive errors Cloudy of ocular media y p y abnormalities Functional visual loss 1.1 myopia 2 1 acute/subacute 3 1 acute/subacute Amblyopia Malingering 1 2 hyperopia 2.1 acute/subacute 2 2 gradual/chronic 3.1 acute/subacute 3 2 gradual/chronic Malingering Hysteria 1.2 hyperopia 2.2 gradual/chronic 3.2 gradual/chronic 1.3 astigmatism 3.3 transient

slide-7
SLIDE 7

Case I Case I

24-year of age, Thai female Problem : Difficult to see the far objects but Problem : Difficult to see the far objects, but she has no problem to read the books HOW DO YOU DO? HOW DO YOU DO?

slide-8
SLIDE 8

Hx & P E

  • Hx. & P.E.
  • No eye pain or

redness

  • VA c glasses

OD 20/40

  • No underlying

diseases OD 20/40 OS 20/70 diseases

  • No ocular trauma

VA OD 20/70

  • VA : OD 20/70

OS 20/100

slide-9
SLIDE 9

VA with correction VA with correction

  • VA c glasses c PH

OD : 20/30 OD : 20/30 OS : 20/30 What is the diagnosis? g How do you do next?

slide-10
SLIDE 10
  • Refraction*

sphere cylinder axis VA OD

  • 3.00

+/-0

  • 20/20

OS

  • 4.00
  • 1.50

90° 20/20

slide-11
SLIDE 11
  • Eye examination must be careful!!!
slide-12
SLIDE 12

Case II Case II

75-year of age, Thai female Problem : Difficult to see the far and near Problem : Difficult to see the far and near

  • bjects in both eyes for 2 years

HOW DO YOU DO? HOW DO YOU DO?

slide-13
SLIDE 13
  • History
  • Slow progressive of
  • Eye examination

VA c glasses : Slow progressive of blur vision

  • Painless

VA c glasses : OD : 20/200 OS HM

  • Painless
  • No underlying

di OS : HM diseases

slide-14
SLIDE 14
  • VA c glasses c PH

OD : 20/70

  • Eye examination
  • RAPD : not present

OD : 20/70 OS : NIPH

p

  • A/S : normal
  • IOP : 18/15 mmHg
  • Fundus :

cupping 0.4 and normal pp g retina OD, abnormal red reflex OU

  • Lens : as the figured
slide-15
SLIDE 15
  • OD
  • OS
slide-16
SLIDE 16
  • What is/are the diagnosis?
  • How do you do?*
  • How do you do?*
  • How is the prognosis in this case?
slide-17
SLIDE 17

Case III Case III

75-year of age, Thai female Problem : Difficult to see the far and near Problem : Difficult to see the far and near

  • bjects in both eyes for 2 years

HOW DO YOU DO? HOW DO YOU DO?

slide-18
SLIDE 18
  • History
  • Slow progressive of
  • Eye examination

VA c glasses : Slow progressive of blur vision

  • Painless

VA c glasses : OD : 20/200 OS CF 2’

  • Painless
  • No underlying

di OS : CF 2’ diseases

slide-19
SLIDE 19
  • VA c glasses c PH

OD : 20/70

  • Eye examination
  • RAPD : not present

OD : 20/70 OS : 20/100

p

  • A/S : normal
  • IOP : 25/30 mmHg
  • Lens : NS 2+
  • Fundus : normal macula

,cupping as the figured

slide-20
SLIDE 20
  • OD
  • OS
  • OD
  • OS
slide-21
SLIDE 21
  • What is/are the diagnosis?
  • How do you do?+
  • How do you do?+
slide-22
SLIDE 22

Case IV Case IV

80-year of age, Thai male Problem : Difficult to see the far and near Problem : Difficult to see the far and near

  • bjects in both eyes for 1 year

HOW DO YOU DO? HOW DO YOU DO?

slide-23
SLIDE 23
  • History
  • Slow progressive,
  • Eye examination

VA c glasses : Slow progressive, painless blur vision, especially central VA c glasses : OD : CF 2’ OS 20/200 especially central vision

  • Farmer

OS : 20/200

  • Farmer
  • Smoking
  • No underlying

diseases

slide-24
SLIDE 24
  • VA c glasses c PH

OD : NIPH

  • Eye examination
  • RAPD : not present

OD : NIPH OS : 20/200

p

  • A/S : normal
  • IOP : 22/23 mmHg
  • Lens : as the figured
  • Fundus : as the figured

g

slide-25
SLIDE 25

Lenses Lenses

slide-26
SLIDE 26

Fundus Fundus

slide-27
SLIDE 27
  • What is/are the diagnosis?*
  • How do you do?
  • How do you do?
slide-28
SLIDE 28

What is this picture? What is this picture?

slide-29
SLIDE 29

Objectives Objectives

  • Characteristics of the optic disc, determining

normal or abnormal optic disc

  • Recognize a cataract and to determine its

approximate potential effect on the patient’s approximate potential effect on the patient s vision, determine whether a cataract is the only cause of a patient’s visual decrease

  • Examine the macula with the ophthalmoscope

and recognize the signs and symptoms of maculopathy

slide-30
SLIDE 30

Glaucoma

slide-31
SLIDE 31

Relevance Relevance

  • Significant cause of irreversible blindness, but

the blindness can be prevented

  • Most patients are asymptomatic, majority of

patients lack of pain, ocular inflammation, or h l halo

  • Peripheral vision can be lost before central

i i vision

  • Visual field defects are characterized by specific

h d d i f i h l shaped scotoma and contraction of peripheral field

slide-32
SLIDE 32
slide-33
SLIDE 33
slide-34
SLIDE 34

Relevance Relevance

  • Early detection of glaucoma is important
  • Usually involves elevation of IOP above the

Usually involves elevation of IOP above the statistically normal range

  • Prolonged elevation of IOP can lead to optic
  • Prolonged elevation of IOP can lead to optic

nerve damage R ti IOP t i l bl

  • Routine IOP measurement is a valuable means
  • f screening of glaucoma
slide-35
SLIDE 35

Relevance Relevance

  • In some cases, glaucomatous optic nerve

changes in normal IOP g

  • Other disorders, such as brain tumor, can also

cause changes in optic nerve cause changes in optic nerve

slide-36
SLIDE 36

Basic information Basic information

Factors effect to IOP

1. Aqueous production : ciliary body epithelium (Non 1. Aqueous production : ciliary body epithelium (Non pigmented epithelium) 2. Resistance to outflow : conventional route (TM) , ( ) unconventional route (Uveoscleral) 3. Episcleral venous pressure

slide-37
SLIDE 37

Basic information Basic information

  • Conventional route

: anterior chamber angle trabecular : anterior chamber angle, trabecular meshwork, Schlemm’s canal, collector channels aqueous vein channels, aqueous vein : >80% of aqueous pass through this route

  • Unconventional route

t i h b i t l f : anterior chamber, intermuscular space of ciliary muscle, suprachoroidal space

slide-38
SLIDE 38
slide-39
SLIDE 39

+

slide-40
SLIDE 40

Basic information Basic information

  • Intraocular pressure
  • All eye have an internal pressure
  • All eye have an internal pressure
  • IOP is largely dependent on the ease of flow to

the trabeculum and Schlemm’s canal the trabeculum and Schlemm s canal

  • Greater the resistance to flow, the higher the

IOP IOP

  • Most normal eyes have an IOP of ≤ 21 mmHg.
slide-41
SLIDE 41

Type of glaucoma Type of glaucoma

  • A. Primary glaucoma
  • 1. Open-angle glaucoma : POAG
  • 2. Angle-closure glaucoma : ACG

2.1 acute ACG : ocular emergency 2.2 subacute ACG 2.3 chronic ACG : CACG

  • B. Congenital glaucoma

1. Primary congenital glaucoma y g g 2. Glaucoma associated with congenital anomalies

slide-42
SLIDE 42

Type of glaucoma Type of glaucoma

  • C. Secondary glaucoma (OAG, ACG or both)
  • pigmentary glaucoma

p g e ta y g auco a

  • pseudoexfoliation glaucoma
  • due to change of the lens
  • due to change of the lens
  • due to change of the uveal tract

d e t tra ma

  • due to trauma
  • neovascular glaucoma

f ll l d

  • following surgical procedure
  • steroid induced glaucoma
  • etc.
slide-43
SLIDE 43
  • Open angle
  • Angle-closure +
slide-44
SLIDE 44

Acute angle closure glaucoma Acute angle closure glaucoma

slide-45
SLIDE 45

Basic information Basic information

  • Optic nerve
  • Composed of more than 1 2 million nerve fibers
  • Composed of more than 1.2 million nerve fibers
  • Nerve fibers originate in the ganglion cells of the

retina retina

  • At the point of origin, the nerve is called the

d ll d ll d h

  • ptic disc, small depression in it called the cup
  • f the optic disc
slide-46
SLIDE 46

Optic nerve Optic nerve

slide-47
SLIDE 47

Basic information Basic information

  • Relationship of IOP and Optic Nerve
  • IOP exerted on walls of the eye including the
  • IOP exerted on walls of the eye, including the
  • ptic nerve and its blood vessels

Damage to the optic nerve results in visual field

  • Damage to the optic nerve results in visual field

loss D f l l l

  • Detection of glaucomatous visual loss is

accomplished by visual field testing

  • VA usually does not suffer initially
slide-48
SLIDE 48
slide-49
SLIDE 49

When to Examine When to Examine

Ophthalmoscopy

  • AAO recommends a glaucoma screening every

AAO recommends a glaucoma screening every 2 to 4 years past age 40

  • Incidence of the disease increases with
  • Incidence of the disease increases with

age,family history and race Af A h k f

  • African-Americans have an greater risk for

development of glaucoma

slide-50
SLIDE 50

How to Examine How to Examine

  • Palpation
  • Tonometry
  • Indentation

: SchiØtz : SchiØtz

  • Applanation
  • Gonioscopy
  • Gonioscopy
  • Perimetry

G ld

  • Goldmann
  • Automated
slide-51
SLIDE 51

Anterior chamber angle Anterior chamber angle

slide-52
SLIDE 52

How to interpret the findings How to interpret the findings

  • Appearance of the optic disc

: Color : Size of cup : Vessels

  • The glaucomatous cupping

: Increase in the size of the optic cup (cup:disc ratio > 0.5 – raises suspicion of glaucoma) V l di l t : Vessel displacement : Asymmetrical cupping (difference > 0.2)

slide-53
SLIDE 53
slide-54
SLIDE 54

+ +

slide-55
SLIDE 55
slide-56
SLIDE 56

Primary open angle glaucoma (POAG) Primary open angle glaucoma (POAG)

  • “Rule of ten”

For every 1 000 persons age over 40 years For every 1,000 persons age over 40 years. – 100 are suspected of POAG by visual field, disc appearance IOP findings or dense risk disc appearance, IOP findings or dense risk factors. 10 h POAG – 10 have POAG. – 1 will be blind as a result of POAG.

slide-57
SLIDE 57

IOP is the greatest risk of POAG IOP is the greatest risk of POAG

  • Other risk factors

1 Old age 1.Old age 2.Family history of POAG 3 Af h 3.African heritage 4.Myopia All of these risk factors are increase risk for presence and progression of POAG. p p g

  • Associated conditions : DM, thyroid, CVS dz.
slide-58
SLIDE 58

Clinical characteristics of POAG Clinical characteristics of POAG

  • Slow progression
  • Most asymptomatic
  • Most asymptomatic
  • Usually bilateral, but may be asymmetry of

severity

  • Normal anterior chamber angle

Normal anterior chamber angle

  • Not found other causes of glaucoma
slide-59
SLIDE 59

Management or Referral Management or Referral

  • ≥ 1 of the following conditions should be

referred to an ophthalmologist :

  • IOP > 21 mmHg
  • IOP not elevated, but a difference ≥ 5 mmHg

between the eyes

  • An optic cup diameter one half or more of the

disc diameter

  • One cup significantly larger in one eye than in

the other eye

  • Symptoms of acute glaucoma
slide-60
SLIDE 60

Glaucoma Treatment Glaucoma Treatment

Goal : preserve normal loss of retinal ganglion

cells with minimal complications p

  • Education
  • Treatment options
  • 1. Medication
  • 1. Medication
  • 2. Laser
  • 3. Surgery

4 Cyclodestructive procedure

  • 4. Cyclodestructive procedure
slide-61
SLIDE 61

Anti-glaucoma drugs Anti-glaucoma drugs

1. β-blocker agents : timolol 2. Non-selective α-adrenergic agonists : di i f i dipivefrin 3. Selective α2 -adrenergic agonists : brimonidine 4 Ch li i d ( i ti ) il i 4. Cholinergic drugs (miotics) : pilocarpine 5. Carbonic anhydrase inhibitors : acetazolamide 6 P t l di d i ti l t t

  • 6. Prostaglandin derivatives : latanoprost,

travoprost, bimatoprost 7 Hyperosmotic agents : glycerine manitol 7. Hyperosmotic agents : glycerine, manitol

slide-62
SLIDE 62

Anti-glaucoma drugs Anti-glaucoma drugs

  • Mechanisms

1 Reduced aqueous production 1. Reduced aqueous production 2. Enhanced outflow : conventional l : unconventional

  • 3. Combined 1.+2.

4. Decrease vitreous volume 5 Neuroprotective

  • 5. Neuroprotective
slide-63
SLIDE 63

Anti-glaucoma drugs Anti-glaucoma drugs

Attention!!!

  • Patient education

Patient education

  • Side effects

C li

  • Compliance
  • Underlying disease : COPD, asthma, CVS dz.,

renal disease

  • History or drug allergy : esp. sulfa
slide-64
SLIDE 64

Laser treatment Laser treatment

  • Argon laser trabeculoplasty (ALT)
  • Selective leser trabeculoplasty (SLT)
  • Selective leser trabeculoplasty (SLT)
  • Laser peripheral iridotomy
  • Laser iridoplasty
slide-65
SLIDE 65
slide-66
SLIDE 66

Surgery Surgery

  • Filtering surgery

:Trabeculectomy +/-

  • Glaucoma drainage

devices :Trabeculectomy / mitomycin C or 5-FU

slide-67
SLIDE 67
slide-68
SLIDE 68

Cyclodestructive procedures+ Cyclodestructive procedures+

slide-69
SLIDE 69

Cataract

slide-70
SLIDE 70
slide-71
SLIDE 71

Relevance Relevance

  • Congenital, genetic anomaly, various diseases,
  • r with increasing age (most common cause)
  • Age-related cataract occurs in about 50% of

people between ages 65 and 74

  • One of the most successfully treated conditions

in all of surgery

  • Usually with intraocular lens implantation
  • If an implant is not used, visual rehabilitation is

still possible with a contact lens or aphakic glasses

slide-72
SLIDE 72

Basic Information Basic Information

  • Lens

Function :

  • refraction : refractive power +20 D
  • accommodation
  • protective function : U.V. , physical barrier

Anatomy : y

  • transparent, biconvex shape
  • thickness ~4 mm. , width ~ 9 mm.
  • capsule, cortex, nucleus
slide-73
SLIDE 73

Basic Information Basic Information

  • Lens

Suspended by thin filamentous zonules

  • Suspended by thin filamentous zonules

(transparent collagen fibers) from the ciliary body body

  • Contraction of the ciliary muscle permits

f i f h l focusing of the lens

  • The lens is encloses in a capsule (elastic

semipermeable basement membrane)

slide-74
SLIDE 74
slide-75
SLIDE 75
slide-76
SLIDE 76

Lens coloboma Zonule

slide-77
SLIDE 77

Basic Information Basic Information

  • Lens

: The capsule encloses the cortex and the : The capsule encloses the cortex and the

nucleus of the lens as well as a single anterior layer of cuboidal epithelium layer of cuboidal epithelium : No innervation or blood supply : Nourishment comes from the aqueous fluid and the vitreous

slide-78
SLIDE 78

Basic Information Basic Information

  • Lens

: Continues to grow throughout life : Continues to grow throughout life : Epithelial cells continue to produce new i l l fib cortical lens fibers : Consists of 35% protein, ~ 60% water by mass : Percentage of insoluble protein increases as the lens ages and as a cataract develops g p

slide-79
SLIDE 79
slide-80
SLIDE 80

Basic information Basic information

  • Cataract
  • Any opacity or

Any opacity or discoloration of the lens, whether a small, local

  • pacity or the complete

loss of transparency Cl ll h

  • Clinically : opacities that

affect visual acuity

slide-81
SLIDE 81

Basic information Basic information

  • Cataract

Opacification of the nucleus and cortex there

  • Opacification of the nucleus and cortex, there

may be a yellow or amber color change to the lens lens

  • May develop very slowly over the years or may

idl d di h d progress rapidly, depending on the cause and type of cataract

slide-82
SLIDE 82

Classification Classification

  • Primary cataract
  • congenital
  • Secondary cataract
  • extraocular disorder
  • congenital
  • juvenile

l

  • extraocular disorder
  • intraocular disorder
  • presenile
  • senile
slide-83
SLIDE 83

Primary cataract Primary cataract

  • Congenital cataract

: <3 mos : <3 mos. : usually unknown cause : may from rubella, steroid, maternal DM, radiation : specific pattern of cataract – polar, suture, lamella cataract a e a cata act

slide-84
SLIDE 84

Lamella cataract Lamella cataract

slide-85
SLIDE 85

Sutural cataract Sutural cataract

slide-86
SLIDE 86

Anterior polar cataract Anterior polar cataract

slide-87
SLIDE 87

Primary cataract Primary cataract

  • Juvenile cataract
  • Presenile cataract : 35 40 years
  • Presenile cataract : 35-40 years
  • Senile cataract : aging process, > 40 years
  • Nuclear sclerosis
  • Cortical cataract ; immature, mature,

Cortical cataract ; immature, mature, intumescent, hypermature, morgagnian cataract Subcapsular cataract ; anterior posterior (may

  • Subcapsular cataract ; anterior, posterior (may

from secondary cause)

slide-88
SLIDE 88
slide-89
SLIDE 89

Hypermature cataract Hypermature cataract

slide-90
SLIDE 90
slide-91
SLIDE 91

Secondary cataract Secondary cataract

  • Extraocular disorder

Traumatic : mechanical physical

  • Traumatic : mechanical, physical
  • Metabolic : DM (fluctuation of vision, myopia),

Wil ’ di (ASC) Wilson’s disease (ASC)

  • Toxic : steroid, echothiophate iodide,

phenothiazines

  • Systemic disease : hyperparathyroidism,

y yp p y myotonic dystrophy, galactosemia, Down’s syndrome, trisomy 18, trisomy 13 y y y

slide-92
SLIDE 92
slide-93
SLIDE 93

Cerulean (blue-dot) cataract Cerulean (blue-dot) cataract

slide-94
SLIDE 94

Oil droplet cataract in Galactosemia Oil droplet cataract in Galactosemia

slide-95
SLIDE 95

Polychromatic (Christmas tree) cataract

slide-96
SLIDE 96

Sunflower cataract Sunflower cataract

slide-97
SLIDE 97

Snowflake cataract Snowflake cataract

slide-98
SLIDE 98

Secondary cataract Secondary cataract

  • Intraocular disorder

uveitis esp chronic uveitis

  • uveitis esp. chronic uveitis
  • retinal detachment
  • retinitis pigmentosa
  • intraocular neoplasm

p

slide-99
SLIDE 99

Basic information Basic information

  • Symptoms of cataract
  • Image blur : depends on the size and location

g p

  • f opacity

: Axial opacities cause much more disabling visual loss than peripheral opacities : Disturbance of vision, diminution, failure of vision : Nuclear sclerosis may become progressively more myopic

slide-100
SLIDE 100

Basic information Basic information

S f ( )

  • Symptoms of cataract (cont.)
  • NS may develop a phenomenon called Second

sight sight

  • Monocular double or multiple images, due to

irregular refraction, prismatic effect within the irregular refraction, prismatic effect within the lens

  • Posterior subcapsular cataract (PSC) may note

p ( ) y a relatively rapid decrease in vision (esp. near vision), with glare as well as image blur and distortion distortion : PSC is frequently associated with metabolic causes : DM, steroid use metabolic causes : DM, steroid use

slide-101
SLIDE 101
slide-102
SLIDE 102
slide-103
SLIDE 103

When to Examine When to Examine

  • A patient with decreasing vision
  • Important to demonstrate that the retina and

Important to demonstrate that the retina and

  • ptic nerve are healthy
  • If the lens is densely cataract
  • If the lens is densely cataract
  • the risk of performing surgery for cataract

ith t th without the assurance

  • RAPD, color test, 4-quadrants light projection
slide-104
SLIDE 104

How to Examine How to Examine

  • Visual acuity
  • Pupillary responses : advanced cataract would

Pupillary responses : advanced cataract would not produce a RAPD

  • Anterior segment examination
  • Anterior segment examination
  • Ophthalmoscopy
slide-105
SLIDE 105

How to Interpret the Findings How to Interpret the Findings

  • Early cataract is not visible to the unaided eye
  • Very dense cataract may appear as a white pupil,

Very dense cataract may appear as a white pupil,

  • r leukocoria
  • Ophthalmoscopy with plus-lens setting
  • Ophthalmoscopy with plus-lens setting
  • partial cataract : black against the red reflex,

th d fl poorer the red reflex

slide-106
SLIDE 106
slide-107
SLIDE 107

Complications of cataract Complications of cataract

  • Phacomorphic glaucoma
  • Phacolytic glaucoma

Phacolytic glaucoma

  • Lens-induced uveitis

Ph h l ti d hth l iti

  • Phaco-anaphylactic endophthalmitis
slide-108
SLIDE 108

Management or Referral Management or Referral

  • Medical : ????

: Mydriatic drug : Mydriatic drug : Treatment of underlying cause or complications complications

  • Indication for surgery
  • 1. Visaul need

2 Complications

  • 2. Complications
  • 3. Posterior segment evaluation
  • 4. Cosmetic
slide-109
SLIDE 109

Cataract surgery Cataract surgery

  • Preoperative evaluation
  • Anesthetic techniques : TA, LA, GA

Anesthetic techniques : TA, LA, GA

  • Surgical techniques : ECCE,PE, PPL, ICCE

P t ti d li ti

  • Postoperative care and complications

management

  • Visual rehabilitation
slide-110
SLIDE 110

Surgical techniques Surgical techniques

  • Extracapsular cataract extraction (ECCE)
  • Phacoemulsification (PE)
  • Intracapsular cataract extraction (ICCE)
  • Pars plana lensectomy (PPL)

p y ( )

  • C

chin

  • Couching
slide-111
SLIDE 111
slide-112
SLIDE 112

Couching Couching

slide-113
SLIDE 113

Visual rehabilitation Visual rehabilitation

  • 1. Aphakic glasses : +10 to +12 D
  • 2. Contact lens : ≥ +10 D
  • 2. Contact lens : 10 D
  • 3. Intraocular lens : ~ +20 D

t i h b l i th b i th

  • posterior chamber lens : in the bag, in the

sulcus, scleral-fixated

  • anterior chamber lens : angle-fixated, iris-

fixated lens

slide-114
SLIDE 114
slide-115
SLIDE 115
slide-116
SLIDE 116

Complications of Cataract Surgery Complications of Cataract Surgery

  • Intraoperative

Expulsive hemorrhage

  • Postoperative

Early p g Iris trauma A/C hemorrhage y : endophthalmitis, glaucoma,

uveitis, iris prolaspe

A/C hemorrhage Ruptured PC Corneal injury Late : posterior capsule opacity, Corneal injury Lens dislocation

p p p y retinal detachment, cystoid macular edema, corneal decompensate decompensate, astigmatism*

slide-117
SLIDE 117

Macular Macular De enerati n Degeneration

slide-118
SLIDE 118

Relevance Relevance

  • Leading cause of irreversible central visual loss

(20/200 or worse) in people over 50 years of ( ) p p y age in U.S.A.

  • Certain types of AMD are treated effectively with

Certain types of AMD are treated effectively with laser

  • Important to recognize this entity and to refer
  • Important to recognize this entity and to refer

for appropriate care

slide-119
SLIDE 119

Basic Information Basic Information

  • Macular Anatomy
  • Oval area

Oval area

  • 2 disc diameter temporal and slightly inferior

to the optic disc to the optic disc

  • Composed of both rods and cones

h ll photoreceptor cell

  • Responsible for detailed, fine, central vision
slide-120
SLIDE 120

Basic Information Basic Information

  • Macular Anatomy

Central macular is avascular and appears

  • Central macular is avascular and appears

darker than the surrounding retina F i l d i i h f

  • Fovea is an oval depression in the center of

macula, there is a high density of cones but no d rods are present

  • The central depression of the fovea may act

like a concave mirror during ophthalmoscopy, producing a foveal reflex

slide-121
SLIDE 121
slide-122
SLIDE 122

Basic Information Basic Information

  • Age-Related Macular changes

1 Drusen

  • 1. Drusen
  • 2. Degenerative change in the retinal

pigmented epithelium (RPE) 3 Subretinal neovascular membranes

  • 3. Subretinal neovascular membranes

(SRNM)

slide-123
SLIDE 123

Drusen Drusen

  • Hyaline nodule (or Colloid bodies) deposited in

Bruch’s membrane

  • Small or large, discrete, irregular shapes, and

indistinct edges

  • Normal, near-normal VA with minimal

metamorphopsia

  • May be seen increasing age, during retinal or

choroidal degeneration in disease states

slide-124
SLIDE 124

Drusen Drusen

slide-125
SLIDE 125

Drusen Drusen

slide-126
SLIDE 126

Degenerative changes in RPE Degenerative changes in RPE

  • May occur with or

without drusen

  • Manifested as clumps of

hyperpigmentation or depigmented atrophic depigmented atrophic areas

  • The effect on visual
  • The effect on visual

acuity is variable

slide-127
SLIDE 127

Subretinal neovascular membranes Subretinal neovascular membranes

  • 20% of eye with

AMD

  • The extension of vessels

from the inner choroid layer into the subretinal space (d f h d l d i (defect has developed in Bruch’s membrane)

slide-128
SLIDE 128

Subretinal neovascular membranes Subretinal neovascular membranes

  • Associated with subretinal hemorrhage, fibrosis,

RPE degeneration, photoreceptor atrophy g p p p y

  • Hemorrhage or subretinal fluid may result in

acute visual loss acute visual loss

  • Larger the membrane and the closer to the

center of the fovea the worse prognosis for center of the fovea, the worse prognosis for good central vision

slide-129
SLIDE 129
slide-130
SLIDE 130

Subretinal neovascular membranes Subretinal neovascular membranes

Other causes of SRNM 1. High myopia 1. High myopia 2. Angioid streaks 3 P d l hi t l i 3. Presumed ocular histoplasmosis 4. Traumatic choroidal rupture

slide-131
SLIDE 131

AMD classification AMD classification

  • Dry AMD ( atrophic,

nonvascular)

  • Wet AMD (vascular,

exudative) )

  • Majority of AMD
  • Suffer mild central visual
  • Subretinal NVM
  • Subretinal scar (disciform

loss

  • Drusen

( scar) 90% of AMD patients with severe i l l

  • Geographic atrophy

(10% of severe visual visual loss loss)

slide-132
SLIDE 132

*

slide-133
SLIDE 133

Dry AMD Dry AMD

slide-134
SLIDE 134

Dry AMD Dry AMD

slide-135
SLIDE 135

Wet AMD Wet AMD

slide-136
SLIDE 136
slide-137
SLIDE 137

When to Examine When to Examine

  • Any patient with decreasing vision
  • Patient with decreased or distorted
  • Patient with decreased or distorted

central vision should be examine the l macula

slide-138
SLIDE 138
slide-139
SLIDE 139

How to Examine How to Examine

  • Visual acuity
  • Amsler grid testing
  • Amsler grid testing
  • Ophthalmoscopy : dilate pupil for adequate

examination

  • Additional studies : stereoscopic slit-lamp

Additional studies : stereoscopic slit lamp

examination, fluorescein angiography

slide-140
SLIDE 140

Amsler grid test Amsler grid test

slide-141
SLIDE 141

Amsler grid Amsler grid

  • Irregularities in lines that are wavy, seem to

bow or bend, appear gray or fuzzy, or absent in pp g y y certain areas, indicating a scotoma

  • Held at normal reading distance of 30 cm. from

Held at normal reading distance of 30 cm. from the eye

  • Measures 10 degree on each side of fixation
  • Measures 10 degree on each side of fixation
  • Allows for an evaluation of 5.36 mm in all

di ectio s f o the ce te of the ac la directions from the center of the macula

slide-142
SLIDE 142

Fluorescein angiography Fluorescein angiography

  • Necessary to identify neovascularization and is

mandatory before considering laser surgery y g g y

  • RPE acts as physical and optical barrier to

fluorescein fluorescein

  • Identification of RPE defects

I d i (ICG) i th d d t

  • Indocyanine green (ICG) is another dye used to

demonstrate new vessels

slide-143
SLIDE 143

Fluorescein angiography Fluorescein angiography

slide-144
SLIDE 144

How to Interpret the Findings How to Interpret the Findings

  • Appearance of the macula often does not

accurately predict the visual acuity y p y

  • Important signs to check for AMD
  • drusen
  • drusen
  • areas of increased or decreased pigmentation
  • subretinal exudate, hemorrhage, NV
  • Absence of foveal reflex and a mottle appearace
  • f the RPE are the early signs of macular disease
slide-145
SLIDE 145

Referral Referral

One or more of the following

  • A recent onset of decreased VA
  • A recent onset of decreased VA
  • A recent onset of metomorphopsia, or

distortion of central vision

  • A recent onset of a scotoma
  • A recent onset of a scotoma
  • Any ophthalmoscopic abnormalities in the

appearance of the macula

slide-146
SLIDE 146

Management* Management

  • 1. Drusen and abnormalities of RPE
  • micronutrient

micronutrient

  • 2. Neovascular membrane complications

fl i i

  • fluorescein angiogram
  • laser treatment
  • photodynamic therapy (PDT)

anti VEGF

  • anti-VEGF
  • surgery
slide-147
SLIDE 147

The Visually Impaired Patient The Visually Impaired Patient

  • The patient with AMD

may have very poor l i i b ill central vision, but will tend to retain functional peripheral vision peripheral vision

  • Visual aids, such as high-

plus magnifiers and p g telescopic devices, may help the pts.

slide-148
SLIDE 148

Diabetic Diabetic Retin ath Retinopathy

slide-149
SLIDE 149

Classification Classification

  • Non proliferative DR (NPDR)

mild

  • mild
  • moderate
  • severe
  • Proliferative DR (PDR)
  • Proliferative DR (PDR)
slide-150
SLIDE 150

Signs & Symptoms Signs & Symptoms

  • NPDR
  • No symptoms
  • PDR
  • No symptoms

No symptoms

  • Vision loss

l d No symptoms

  • Vision loss

NPDR : lens edema : macular edema : as NPDR : VH : CSME : cataract : TRD +/- RRD : NVG : macular ischemia

slide-151
SLIDE 151

NPDR NPDR

slide-152
SLIDE 152
slide-153
SLIDE 153
slide-154
SLIDE 154
slide-155
SLIDE 155
slide-156
SLIDE 156
slide-157
SLIDE 157
slide-158
SLIDE 158
slide-159
SLIDE 159
slide-160
SLIDE 160

PDR PDR

slide-161
SLIDE 161
slide-162
SLIDE 162
slide-163
SLIDE 163
slide-164
SLIDE 164
slide-165
SLIDE 165

NVI NVI

slide-166
SLIDE 166

Treatment Treatment

  • Control hyperglycemic status
  • Control hypertension anemia
  • Control hypertension, anemia,

hyperlipidemia

  • F/U : duration????
  • Laser photocoagulation

Laser photocoagulation

  • Surgical intervention
slide-167
SLIDE 167

Intravitreal injection Intravitreal injection

slide-168
SLIDE 168

Focal laser photocoagulation Focal laser photocoagulation

slide-169
SLIDE 169

Pan retinal laser photocoagulation Pan-retinal laser photocoagulation

slide-170
SLIDE 170

Pars plana vitrectomy Pars plana vitrectomy

slide-171
SLIDE 171

Refractive Errors & Refractive Errors & Presbyopia Presbyopia

slide-172
SLIDE 172

Formation of Vision Formation of Vision

  • Light from object
  • Refraction by optical element
  • Refraction by optical element
  • Image formation on retina
  • Conversion into neural signals
  • Perception by the brain
  • Perception by the brain
slide-173
SLIDE 173

The Evolution of the Refractive State The Evolution of the Refractive State

  • Hyperopia in newborn (2D)
  • Gradual shift toward emmetropia
  • Gradual shift toward emmetropia
  • Emmetropization
  • More genetic than environmental
  • Affected by ocular and systemic diseases
  • Affected by ocular and systemic diseases,
  • cular surgery, etc
slide-174
SLIDE 174

The Focusing element The Focusing element

  • Cornea

most powerful +43 D

  • most powerful +43 D
  • Crystalline lens : +20 D
  • Accommodation
slide-175
SLIDE 175

Refractive Errors (Ametropia) Refractive Errors (Ametropia)

= Defocusing

slide-176
SLIDE 176

Defocusing and Aperture Defocusing and Aperture

slide-177
SLIDE 177
slide-178
SLIDE 178

Myopia Near Sightedness Myopia, Near Sightedness

slide-179
SLIDE 179

Hyperopia Far Sightedness Hyperopia, Far Sightedness

slide-180
SLIDE 180

Astigmatism Astigmatism

slide-181
SLIDE 181

Astigmatism Astigmatism

slide-182
SLIDE 182
slide-183
SLIDE 183

Presbyopia Old Eyes Presbyopia, Old Eyes

  • Physiologic decrease of accommodation
  • Not a true refractive error

Not a true refractive error

  • Over 40 years of age

N d l l t l

  • Need plus lenses to see up close
slide-184
SLIDE 184

Refraction Refraction

  • Measuring refractive errors
  • Types : manifest cycloplegic
  • Types : manifest.,cycloplegic
  • Methods
  • 1. Objective : retinoscopy, autorefractor

2 Subjective :

fi t

  • 2. Subjective : refinement
slide-185
SLIDE 185
slide-186
SLIDE 186

Correcting Refractive Errors Correcting Refractive Errors

  • Spectacles
  • Contact lenses
  • Contact lenses
  • Surgery (refractive surgery)
slide-187
SLIDE 187
  • *